Comparing tumor treatment landscape between the United States and Europe reveals key disparities. Generally , US medical systems tend to a more advanced and often high-priced approach, driven by innovation and consumer-driven decisions. Conversely , European networks stress universal access and v

While both the United States and Europe strive to provide excellent cancer care, their systems differ substantially. The US often emphasizes innovative treatments, sometimes leading to increased costs. In contrast, European systems tend to prioritize holistic care and affordability, highlighting